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Untuk menilai efektivztas pemoerian vitamin A dosis tznggz (200.000 IU vitamin A dan 40 I U ,  
vit~min E) secara masal dalam usaha pencegahan xerophthalmia, dilakukan penelitian terhadap seluruh i 
anak umur 1-5 tahztn di tujuh RK kotamadya Salatiga dan lirtaa desa kabupaten Semarang, oleh suatu 
team ophthalmologi. 
Pada pemeriksaan awal ditemukan 132 penderita xerophthalhia diantara 2812 anak (4,7 persen). 
Kepada 2680 anak yang tidak menderita xerophthalmia sebagian diberi kapsul vitamin A dosis tinggi dan 
sebagian lain diberi kapsul placebo yang identik, secara "double-blind" diperiksa ulang sesudah enam I 
bulan. Ternyata bahwa 7 diantara 1286 anak penerima vitamin A yang diperiksa (0,5 persen) 
menunjukkan tanda-tanda xerophthalmia. Sedang diantara 1183 anak penerima placebo yang diperiksa 
ternyata terdapat 43 penderita xerophthalmia (3.6 persen). Secara statistik bedanya amat bermakna. 
Tanda-tanda rltama yang ditemukan adalah kombinasi dari buta-senja, xerosis conjunctiva, dan bercak 
Bitot. Kedua tanda Yang terakhir ini terdapat pada 90 persen dari penderita, sedang buta-senja hanya 15 
persen. Pada pemeriksaan ulang 132 anak penderita xerophthalmia yang telah diberi kapsul vitamin A 
dosis tinggi temyata bahwa 91 persen dan yang diperiksa tidak lagi memperlihatkan tanda-tanda I 
xeroph thalmia. Jumlah anak yang tidak dapat diperiksa kem bali jauh dibawah angka perkiraan. 
Sebagian besar karena telah pindah alamat, sebagian kecil meninggal. 
Antara golongan placebo dan vitamin, jumlah anak yang tidak dapat dipenksa kembali ini sama besar. 
Penelitian ini membuktikan bahwa kapsul vitamin A dosis tinggi efektip sekali untuk mencegah 
timbulnya xerophthalmia dan menyembuhkan gejala-gejala xerophthalmia nngan. 
Vitamin A deficiency clinically expressed various studies sh'owed evidence suggesting that 
by signs of xerophthalmia is considered to be a massive dose of vitamin A resulted in adequate ' 
significant public health problem in Indonesia. shum levels of vitamin A for up to six m ~ n t h s ,  
The prevalence rates range from 4 to 17 per cent with the implication that these levels were 
of certain pre-school age population groups. Eye sufficient to prevent the development of eye 
signs related to vitamin A deficiency are also felt signs of deficiency. i 
to be related with high mortality rates at these Based on these facts, the Government of 
ages. Indonesia has undertaken a pilot project of At the WHO Consultation on Prevention of distribution of oral massive dose vitamin A to Xeropl~thalmia in ~ ~ d e r a b a d  in ~ a r c l l  1973, pre-school children in selected areas of java. i 
Because of the im~lications of o ~ ~ o r t u n i t v  cost I 
1 A 
* This paper is presented by Slamet Santoso at the as well as direct costs for personnel and material, 
WHO Meeting on the Control of Vitamin A 
Deficiency, Jakarta November 25-29th 1974. it was deemed advisable to  concurrentlv ' carrv I I 
1 .  Academy of Nutrition, Ministry of Health Jakarta. observation on the biolbgical 2. Provincial Health Service. Semarang 
3. Bendungan Eye Hospital Semarang effectiveness of the massive dose capsule in term 
4. American Foundation for Overseas Blind. New York of availability to prevent the o~cumence of 5. Eye Division Ministry of Health Jakarta. 
(Received 30 November lQ741. clinical eve siens. 
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Evaluation of both aspects operational and biolo- / gical aspects of preventive program has been an 
agreement with the American Foundation for 
1 Overseas Blind. 
MATERIALS AND METHODS 
The sample of children studied consisted of 
all children aged 1-5 years residing in seven 
urban kampungs and five rural villages in Central 
Java, an area where xerophthalmia is known t o  
occur although the exact prevalence was un- 
k n ~ w n - ~ r i o r  t o  the study. 
A preliminary census and registration of all 
children was performed. 
A double-blind prospective experimental/ 
placebo study was designed with determination 
of xerophthalmia by examination teams at  six 
months interval following an initial baseline 
examination with removal of cases. The study 
was intended t o  demonstrate a 50-70 per cent 
reduction in point prevalence of xerophthalmia 
resulted from the administration of massive-dose 
vitamin A. The sample was calculated according- 
ly on the basis of an estimated prevalence figure 
of 7 per cent, with an overage of 56 and 3 0  per 
cent for urban and rural respectively to  account 
for possible dropout from mortality, migration, 
uncooperation, xerophthalmia occuring during 
the study. 
At the initial baseli'ne examination, chil- 
dren with xerophthalmia were treated with 
vitamin .A capsule and removed from the study. 
although they were observed for response t o  the 
capsule. The remainder of the children were 
numbered and dosed with either vitamin A 
(200.000 IU vitamin A with 4 0  IU vitamin E in 
oil) or placebo in identical capsules, according to 
their code number. Dosing was repeated at  six 
months interval with eye examination. 
Two teams, urban and rural, conducted the 
examination. Each consisted of an ophthalmolo- 
gist, two eye nurses, 'and local administrative 
aides. 
Both teams were under. close supervision of a 
principal investigator. 
Those children indicating one or a combinating 
of signs of night-blindness, conjunctival xerosis, 
corneal cerosis, Bitot's spot,  Keratomalacia were 
documented as xerophthalmia cases. No member 
of the team knew before the code was broken 
which was the experimental and which was the 
control group. 
Exalnination were conducted at selected points 
in each village. Clinical examination forms were 
completed for each child. The forms for identifi- 
ed cases were tabulated for age, sex, diagnostic 
findings, and site of residence. 
RESULTS AND DISCUSSlON 
- .  
The results of initial baseline examination 
are shown 'in tables below. Table 1 shows the 
prevalence rates of 4.5 and 5.2 per cent in urban 
and rural respectively, with an overall prevalence 
of 4.7 per cent. 
Fable 1. Baseline examination: total xeroph- 
thalmia cases among examined children aged 
12 - 60 months. 
Urban Rural Total 
n=1438 n=1374 ~ 2 8 1 2  
Xerophthalmia cases 6 1 71 132 
Prevalence rate percent 4.3 5.2 4.7 
Table 2 indicates the number of xerophthalrnia 
cases by age and place of residence. There are 
apparently more cases in older children. 
As shown in table 3 there is an  obvious difference 
in the prevalence rate between boys and girls. 
Table 2. Baseline examination: Total xeroph 
thalmia cases by age and place of residence. 
Age 12-24mo 25-36mo 37-48mo 40-60mo Total 
Residence n=667 n=732 n=748 n=665 n=281 
Urban 1 15 24 2 1 61 
Rural 3 9 26 33 7 1 
Total 4 24 50 54 132 
Percent 0.6 3.3 6.7 8.1 
At the time of the repeat examination a 
strong effort was made to locate and examine 
those children who were initially identified as 
having xerophthalmia and treated with a massive- 
dose of vitaniin A. 
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Table 3. Baseline examination: Total xeroph- 
thalmia cases by sex and place of Residence. 
Urban Rural Total 
Boys n = 1409 37 47 84 
Girls n =  1403 24 24 48 
As shown in table 4 over 9 0  per cent of those 
examined were free from signs of xerophthalmia. 
Table 4. Results of treatment with massive dose 
vitamin A :  re-examination of xerophthalmia 
cases six mon.ths after baseline. 
Urban Rural Total 
Total cases 61 7 1 132 
Re-exami ned 57 61 118 
Recovered 49 58 107 
Per cent 85 95 91 
The results of the repeat examination are 
presented in tables 5-7. 
Table 5 indicates total cases of xerophthalmia in 
experimental and control group at six months 
after baseline. Seven cases were found among 
1286 children (0.5 per cent) in the experimental 
group and 43 among 1183 children (3.6 per cent) 
in the control, the difference of whicll is highly 
significant. 
The problem of sample size was the major 
distraction from the study design. As the exact 
prevalence in the study area was unknown, an 
estimated rate of 7 per cent was chosen, which 
was found later t o  be 4.7 per cent. The dropout 
from mortality, migration, uncooperation, and 
xerophthalmia was, on the other hand, much less 
than the average figure. 
The clinical form for recording was found 
to be too long and detailed. Revision and 
improvement of this form represents a contribu- 
tion to  further field studies. 
As in similar studies, the use of night-blindness 
unconfirmed by objective testing is a criteria of 
iubious value. Results of the initial baseline 
:xaminations indicated a need for more thorough 
nter examiner standardization on criteria. 
:ontinuous surveillance of the study population 
vould have been ideal, but was not  possiblc. 
Table 5. Repeat examination: Total cases of 
xerophthalmia six months ater baseline, by place 
of Residence and study group. 
Experimental Control Total 
Urban Xerophthalmia 3 16 19 
Examined 623 599 1222 
- 
Rural Xerophthalrnia 4 27 31 
Examined 663 584 1247 
Total Xerophthalmia 7 43 50 
Examined 1286 1183 2469 
Table 6. Repeat examination: Total children 
missed six months after by study group and 
cause. 
Urban Rural 
Expr Cont Total Expr Cont Total 
n=669 n=678 n=1377 n=691 n=612 n=1303 
- - -  
Mortality 4 6 10 6 6 12 
Migration 45 42 87 17 18 35 
Uncoope- 
ration 27 31 58 5 4 9 
Total 76 79 155 28 28 56 
11.2 per 4.3 per 
cent cent' 
Table 7. Repeat examination: Important diag-1 
nostic findings six months after baseline, by 
place of Residence. I 
Urban Rural 
n=19 nr31 
Nightblind 3 4 
16 percent 13 percent 
Conjunctival dryness, 18 30 
wrinkling, thickening 95 percent 97 percent 
Bitot's spot 16 31 
84 percent 100 percent 
Although children found t o  have xerophthalmia 
were observed for the results of vitamin A 
treatment on the eye signs, there was n o  accumu- 
lation of detailed biologic and sociologic data on 
these children and their families. Such data might 
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be useful in assembling a profile of children at 
risk for xerophthalmia. 
The development of an effective and efficient 
program depends on the understanding of the 
epidemiological aspects of the problem being 
attacked. Prevention of blindness a related to 
vitamin A deficiency has consisted of secondary 
prevention, i.e. the recognition of certain eye 
signs thought to be precursors of events which 
impair vision, and therapy with vitamin A to 
prevent such progression. Primary prevention 
would consist of assuring adequate intake and 
stores of the vitamin in population at risk. 
For the purpose of this study, the assump- 
tion was made that xerophthalmia stands clear- 
lv within the spectrum of biological change 
denotlng vitamln A deficiency, and that persons 
with xerophthalmia are at higher risk than others 
of progressing in some fashion to visual impaire- 
ment including blindness. 
Theoretically, the prevention of the lesser stages 
of xerophthalmia is well correlated with preventi- 
on of blindness. By stating this, it is meant that 
the present stuuy measures the effect of vitamin 
A in. preventing xerophthalmia, and only indirec- 
tly to the extent that xerophthalmia is in fact a 
precursor of blinding disease, its effect in pre- 
venting blindness. 
The decision to base the study in observati- 
on of eye signs represents a compromise, in light 
of more recent data on serum levels of vitamin A. 
Serum studies are more objective than the rather 
subjective clinical examinations, but have also 
been difficult of interpretation, at least until 
studies of liver stores began to clarify the 
physiology of vitamin A and its plzarmacodyna- 
mics. The hlghly significant difference between 
incidence in the experimental an control group 
suggest that oral massive-dose of vitamin A in oil 
is indeed effective in preventing clinical signs of 
xerophthalrnia. 
Although further studies are needed to elucidate 
the relationship between clinical signs and 
biochemical events, it is hoped that these data 
will be useful to decision makers contemplating 
preventive programs. 
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